Unknown

Dataset Information

Impact of the corticosteroid indication and administration route on overall survival and the tumor response after immune checkpoint inhibitor initiation.


ABSTRACT:

Background

Based on their indications, systemic corticosteroids appear to negatively affect clinical outcomes in immune checkpoint inhibitor (ICI)-treated patients. There are few data on the influence of topical and inhaled corticosteroids on the ICIs' effectiveness.

Methods

In a single-center study, we retrospectively investigated the impact of systemic corticosteroids according to their indication [an immune-related adverse event (irAE) or another indication] on overall survival (OS) and the tumor response in all consecutive patients after initiation of ipilimumab, nivolumab or pembrolizumab over a 9-year period. The impacts of topical and inhaled corticosteroids were also examined.

Results

Three hundred and seventy-two patients were included. The mean ± standard de

SUBMITTER: Gaucher L 

PROVIDER: S-EPMC7923985 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature